Thalassemia News and Research

Latest Thalassemia News and Research

Scientists design new system for molecular blood group typing

Scientists design new system for molecular blood group typing

Emmaus reports preliminary top-line results from Phase 3 clinical trial for treatment of sickle cell disease

Emmaus reports preliminary top-line results from Phase 3 clinical trial for treatment of sickle cell disease

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

Emmaus completes all patient visits for Phase 3 trial of L-glutamine for treatment of sickle cell disease

New projects advance treatments for radiation syndrome, cardiac arrest-induced brain injury and rare blood disorder

New projects advance treatments for radiation syndrome, cardiac arrest-induced brain injury and rare blood disorder

Alnylam initiates Phase II study with ALN-TTRsc for treatment of ATTR

Alnylam initiates Phase II study with ALN-TTRsc for treatment of ATTR

Acetylon Pharmaceuticals presents positive preclinical data for selective HDAC1/2 inhibitors at ASH meeting

Acetylon Pharmaceuticals presents positive preclinical data for selective HDAC1/2 inhibitors at ASH meeting

Alnylam presents new pre-clinical data with ALN-AT3 for treatment of hemophilia and RBD

Alnylam presents new pre-clinical data with ALN-AT3 for treatment of hemophilia and RBD

Acetylon announces positive preclinical data of ricolinostat (ACY-1215) in models of lymphoma

Acetylon announces positive preclinical data of ricolinostat (ACY-1215) in models of lymphoma

Acetylon Pharmaceuticals presents positive interim data from two ricolinostat clinical trials at ASH 2013

Acetylon Pharmaceuticals presents positive interim data from two ricolinostat clinical trials at ASH 2013

Genetically engineered cell therapies demonstrate early efficacy, safety in patients with blood disorders

Genetically engineered cell therapies demonstrate early efficacy, safety in patients with blood disorders

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

CHEO-led study confirms validity, reliability of quality of life measurement tool for thalassemia major

CHEO-led study confirms validity, reliability of quality of life measurement tool for thalassemia major

IVF and chromosome testing: an interview with Dr. Santiago Munné

IVF and chromosome testing: an interview with Dr. Santiago Munné

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Scientists uncover new approach to develop induced pluripotent stem cells for in vivo disease modeling

Scientists uncover new approach to develop induced pluripotent stem cells for in vivo disease modeling

Study: Ciclopirox drug completely eradicates infectious HIV from cell cultures

Study: Ciclopirox drug completely eradicates infectious HIV from cell cultures

Global Industry Analysis Report on Companion Diagnostics Market

Global Industry Analysis Report on Companion Diagnostics Market

Sangamo BioSciences signs definitive agreement to buy Ceregene

Sangamo BioSciences signs definitive agreement to buy Ceregene

FDA grants Orphan Drug Designation to Alnylam ALN-AT3 for treatment of hemophilia B

FDA grants Orphan Drug Designation to Alnylam ALN-AT3 for treatment of hemophilia B